Penta investigates cases of acute hepatitis of unknown origin in children
RBDCOV initiates the first Phase III clinical trial of HIPRA’s Covid-19 vaccine in immunocompromised people
Capacitating the future of research in paediatric HIV
Case numbers of acute hepatitis of unknown aetiology among children in 24 countries up to 18 April 2022 compared to the previous 5 years
The EPIICAL story
The D3 study has screened the first 2 children
🇬🇧 GARDP study reveals that babies are increasingly dying of neonatal sepsis caused by drug-resistant bacterial infections
🇮🇹 Uno studio di GARDP rivela che i neonati muoiono sempre più frequentemente per sepsi neonatale causata da infezioni batteriche resistenti ai farmaci
